Joshua M. Bernstein is a journalist specializing in beer, spirits, food, travel, and other intoxicating ways of the world, as well as an occasional tour guide, event producer, and consultant. He writes for The New York Times, Men’s Journal, New York magazine, Wine Enthusiast, and Imbibe, where he’s a contributing editor in charge of beer coverage. Bernstein is also the author of five books: Brewed Awakening, The Complete Beer Course, Complete IPA, Homebrew World, and Drink Better Beer. He lives with his wife and daughter in Brooklyn, where he likes riding his bikes and eating dumplings.
For years, bars and restaurants have served of-age customers their favorite alcoholic drinks. Meanwhile, cannabis consumption almost exclusively occurs in private, even in states that have legalized recreational sales. That’s because most states have been slow to establish and approve social consumption licenses. But as laws and attitudes loosen, on-premise consumption is slowly coming of age.
In early August, some of the first cases of vaping-related lung injuries, known as EVALI, began to surface. Fast forward three months, and more than 2,000 EVALI cases have since been documented by the Centers for Disease Control and Prevention, which is pointing to vitamin E acetate as a leading culprit. So where does the cannabis industry go from here?